Company profile
Nanopharm Limited
Your Respiratory Drug Delivery Specialists - Nanopharm Ltd
Nanopharm provide unique technologies and formulation development tools enabling pre-clinical development through to clinical manufacture of OINDPs.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MzQzNzY0Njc2NWFkaXF6a2N4
Published 29 Sep 2024 01:38
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Delivery of a Flexible, Agile and Sustainable Supply Chain for the Development of a Generic Triple Dry Powder Inhaler Formulation
1 Jul 2024 to 31 Mar 2026
The annual economic burden of asthma and chronic obstructive pulmonary disease (COPD) on the NHS in the UK is in the order of £4.9 billion. A National Institute of Health and Care Excellence (NICE) statement suggests that two thirds of asthma deaths would be preventable with better access to basic care and the right treatment. Latest guidelines for treatm...